Innate Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Innate Pharma and buy or sell other stocks, options, and ETFs commission-free!

About IPHA

Innate Pharma SA is a biopharmaceutical company, which engages in improving oncology treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Its product pipeline include Lacutamab, Monalizumab, Avdoralimab, and IPH62. 

CEO
Hervé Eloi Dominique Brailly
CEOHervé Eloi Dominique Brailly
Employees
210
Employees210
Headquarters
Marseille, Provence-Alpes-Cote-dAzur
HeadquartersMarseille, Provence-Alpes-Cote-dAzur
Founded
1999
Founded1999
Employees
210
Employees210

IPHA Key Statistics

Market cap
229.59M
Market cap229.59M
Price-Earnings ratio
-28.29
Price-Earnings ratio-28.29
Dividend yield
Dividend yield
Average volume
9.68K
Average volume9.68K
High today
$2.90
High today$2.90
Low today
$2.38
Low today$2.38
Open price
$2.38
Open price$2.38
Volume
57.65K
Volume57.65K
52 Week high
$3.57
52 Week high$3.57
52 Week low
$1.81
52 Week low$1.81

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.